World Biotech API Market Potential Examined in New Topical Study Now Available at MarketPublishers.com

New market research study “Global Biotech API Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd. The study reports that the global API market has been advancing at a significant growth rate in recent times and it is likely to register a healthy CAGR of around 8% during 2012-2015.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
TD The Market Publishers, Ltd

http://marketpublishers.com/

London, UK (PRWEB) June 20, 2012

The global API market has been advancing at a significant growth rate in recent times and it is likely to register a healthy CAGR of around 8% during 2012-2015, supported by factors such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological innovation to drive HPAPI segment, as well as impressive participation of private players.

Biotech APIs have a very low share in the global API market with synthetic APIs accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech APIs are sure to see a highly prospective market in the future. The branded APIs currently dominate the biotech APIs market; however, with growing patent expiries and advancements in the market structure, the generic APIs will see a rapid growth.

New market research study “Global Biotech API Market Analysis” elaborated by RNCOS E-Services has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Biotech API Market Analysis
Published: June, 2012
Pages: 60
Price: US$ 1,000.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/global_biotech_api_market_analysis.html

The study presents unbiased analysis and forecast for the biotech API market from a global perspective. It analyses the regulatory structure in the API and the biotech API market covering the mandates and guidelines for manufacturing, safety, and good manufacturing practices (GMP). The report also provides elaborate profiles the top companies involved in the biotech API business to gain insights on their overall business, biotech API functioning, recent activities, along with analysis of their strengths and weaknesses. Furthermore, prudent market segmentation and forecasts; the geographic analysis and regulatory overview can also be found in the review.

Companies discussed include: Bayer Pharma AG, Bayer Pharma AG, Boehringer Ingelheim, Hospira, Lonza, Ranbaxy Laboratories, Royal Dsm N.V., Sigma-Aldrich, Teva Active Pharmaceutical Ingredients, Zhejiang Hisun Pharmaceutical Co. Ltd.

Report Contents:

1. Analyst View

2. Research Methodology

3. Biotech Active Pharmaceutical Ingredients - an Introduction

4. Active Pharmaceutical Ingredient - Industry Performance

4.1 Current and Future Market Analysis to 2015
4.2 Branded and Generic APIs
4.3 Synthetic and Biotech APIs

5. Biotech Active Pharmaceutical Ingredients - Industry Performance

5.1 Current and Future Market Analysis to 2015
5.2 Biogeneric and Innovator Biotech APIs
5.3 Key Geographical Markets

6. Regulatory Environment

7. Competitive Landscape

7.1 Bayer Pharma AG
7.1.1 Business Overview
7.1.2 Strengths and Weaknesses
7.1.3 Recent Developments
7.2 Biocon Limited
7.2.1 Business Overview
7.2.2 Strengths and Weaknesses
7.2.3 Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Business Overview
7.3.2 Strengths and Weaknesses
7.3.3 Recent Developments
7.4 Hospira
7.4.1 Business Overview
7.4.2 Strengths and Weaknesses
7.4.3 Recent Developments
7.5 Lonza
7.5.1 Business Overview
7.5.2 Strengths and Weaknesses
7.5.3 Recent Developments
7.6 Ranbaxy Laboratories
7.6.1 Business Overview
7.6.2 Strengths and Weaknesses
7.6.3 Recent Developments
7.7 Royal Dsm N.V.
7.7.1 Business Description
7.7.2 Strengths and Weaknesses
7.7.3 Recent Developments
7.8 Sigma-Aldrich
7.8.1 Business Overview
7.8.2 Strengths and Weaknesses
7.8.3 Recent Developments
7.9 Teva Active Pharmaceutical Ingredients
7.9.1 Business Overview
7.9.2 Strengths and Weaknesses
7.9.3 Recent Developments
7.10 Zhejiang Hisun Pharmaceutical Co. Ltd.
7.10.1 Business Overview
7.10.2 Strengths and Weaknesses
7.10.3 Recent Developments

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2011)
Figure 4-3: Global - Share of Branded and Generic APIs in API Merchant Market (2011)
Figure 4-4: Global - Share of Synthetic and Biotech APIs in API Market (2011)
Figure 5-1: Global - Biotech API Market (Billion US$), 2011-2015
Figure 5-2: Global - Share of Biogeneric and Innovator APIs in Biotech API Market by (2011)
Figure 5-3: Global - Biotech API Market by Country (%), 2011

More new market research reports by the publisher can be found at RNCOS E-Services page.


Contact